Smart Insulin Pen: Opportunities, Challenges and Vulnerabilities
Diabetes management has steadily advanced along with the development of new technology. An important step in improving insulin delivery was the introduction of smart insulin pens that enhanced dosing accuracy and convenience of use. Smart Insulin Pens (SIPs) revolutionized diabetes care by introducing real time wireless connectivity, digital dose tracking, and integration with personalized dosing support. With automatic dose capture, reviewing insulin dose data became more effective, especially when paired with blood glucose data. This technology enabled patients, healthcare providers, and diabetes care teams to make data driven decisions and recommendations in real time. Improved diabetes management decisions became possible within a continuous and asynchronous framework with the use of SIPs. Manufacturers of insulin pens aim their efforts at further automation with more advanced software and integrated machine learning within SIPs. The role of technological advancements in diabetes care cannot be dismissed or undermined due to numerous benefits and opportunities modernized diabetes care carries. However, there are important challenges and vulnerabilities associated with technological advancements that this blogpost aims to discuss.